Similar risk of exercise‐related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross‐over trial

We compared changes in blood glucose (BG) and risk of hypoglycaemia during and after exercise in 40 patients with type 1 diabetes (T1D) treated with insulin degludec (IDeg) or insulin glargine (IGlar) in a randomized, open‐label, two‐period, crossover trial. After individual titration and a steady‐s...

Descripción completa

Detalles Bibliográficos
Autores principales: Heise, T., Bain, S. C., Bracken, R. M., Zijlstra, E., Nosek, L., Stender‐Petersen, K., Rabøl, R., Rowe, E., Haahr, H. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063138/
https://www.ncbi.nlm.nih.gov/pubmed/26450456
http://dx.doi.org/10.1111/dom.12588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063138/
https://www.ncbi.nlm.nih.gov/pubmed/26450456
http://dx.doi.org/10.1111/dom.12588

Ejemplares similares